(Q36517000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1679671%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

review article

1 reference

title

Role of acid suppressants in patients with Zollinger-Ellison syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1679671%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Role of acid suppressants in patients with Zollinger-Ellison Syndrome (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

27 October 2022

author name string

P. N. Maton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679671

27 October 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1679671%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.1991.tb00746.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.1991.tb00746.x/fullpdf

27 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Alimentary Pharmacology & Therapeutics

27 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1679671%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

5 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1679671%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

25-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1679671%20AND%20SRC:MED&resulttype=core&format=json

Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Zollinger-Ellison Syndrome: Current Concepts and Management

27 October 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Reflux esophagitis in patients with Zollinger-Ellison syndrome

27 October 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Zollinger-Ellison syndrome. Current concepts in diagnosis and management

27 October 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES

27 October 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Current management of Zollinger-Ellison syndrome.

27 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Surgical management of the Zollinger-Ellison syndrome.

27 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists. A prospective study.

27 October 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome

27 October 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study

27 October 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome

27 October 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome

27 October 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Cimetidine treatment of acute and chronic zollinger-ellison syndrome

27 October 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Famotidine in the therapy of gastric hypersecretory states

27 October 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states

27 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Effect of isopropamide on response to oral cimetidine in patients with Zollinger--Ellison syndrome.

27 October 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Cimetidine in the treatment of Zollinger-Ellison syndrome

27 October 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Basis for failure of cimetidine in patients with Zollinger-Ellison syndrome

27 October 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Failure of histamine H2-receptor antagonist therapy in Zollinger-Ellison syndrome

27 October 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study

27 October 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study

27 October 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists

27 October 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome

27 October 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

The achlorhydria-carcinoid sequence: role of gastrin

27 October 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Endocrine cell proliferation and carcinoid development: a review of new aspects of hypergastrinaemic atrophic gastritis

27 October 2022

40

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Gastric carcinoids and related endocrine growths

27 October 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells

27 October 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery

27 October 2022

43

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00746.X

27 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1679671%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference